abatacept
Showing 1 - 25 of 323
Healthy Participants Trial in Cypress, Miami, Las Vegas (Abatacept)
Not yet recruiting
- Healthy Participants
- Abatacept
-
Cypress, California
- +2 more
Aug 1, 2023
Kidney Transplant Recipient Trial in Atlanta (Abatacept 125Mg/Ml Syringe)
Not yet recruiting
- Kidney Transplant Recipient
- Abatacept 125Mg/Ml Syringe
-
Atlanta, Georgia
- +1 more
Aug 2, 2023
Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)
Recruiting
- Type 1 Diabetes
- Diabetes Mellitus, Type 1
- Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
- Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
-
Westmead, New South Wales, Australia
- +5 more
Feb 15, 2023
Eye Diseases, Uveitis Trial in Leuven (Abatacept 125 MG/ML Prefilled Syringe)
Active, not recruiting
- Eye Diseases
- Uveitis
- Abatacept 125 MG/ML Prefilled Syringe
-
Leuven, Vlaams-Brabant, BelgiumUZLeuven
Jan 26, 2023
Interstitial Lung Disease, Common Variable Immunodeficiency Trial in Cincinnati (Abatacept, Placebo)
Recruiting
- Interstitial Lung Disease
- Common Variable Immunodeficiency
- Abatacept
- Placebo
-
Rochester, Minnesota
- +1 more
Nov 18, 2022
Peanut Allergy Trial in Montréal (Abatacept, Placebo, Peanut oral immunotherapy)
Recruiting
- Peanut Allergy
- Abatacept
- +2 more
-
Montréal, Quebec, CanadaCHU Sainte-Justine
Dec 6, 2022
Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)
Recruiting
- Abatacept
- +2 more
- Janus Kinase Inhibitor
- Abatacept
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Jul 5, 2022
Myocarditis Trial (Abatacept 250 MG)
Not yet recruiting
- Myocarditis
- Abatacept 250 MG
- (no location specified)
Jul 5, 2022
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
T and B Cell Repertoire Changes in Response to Orencia® in
Recruiting
- Rheumatoid Arthritis
-
New York, New YorkHospital for Special Surgery
Mar 13, 2023
Rheumatoid Arthritis, Rheumatic Diseases Trial in Leiden (Abatacept, Methotrexate)
Completed
- Rheumatoid Arthritis
- Rheumatic Diseases
- Abatacept
- Methotrexate
-
Leiden, NetherlandsLeiden University Medical Center
Aug 16, 2022
Rheumatoid Arthritis Trial in Lenexa, San Antonio, Salt Lake City (Test Product, Reference product, Reference Medicinal Product)
Recruiting
- Rheumatoid Arthritis
- Test Product
- +2 more
-
Lenexa, Kansas
- +2 more
Nov 8, 2023
Rheumatoid Arthritis Trial in Lebanon (Abatacept, DMARDs)
Active, not recruiting
- Rheumatoid Arthritis
- Abatacept
- DMARDs
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jul 22, 2022
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)
Active, not recruiting
- Graft-versus-host Disease
- Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
-
New York, New YorkNYU Langone Health
Aug 5, 2022
CTLA4 Haploinsufficency, Chronic Cytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- CTLA4 Haploinsufficency
- Chronic Cytopenia
- abatacept
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Giant Cell Arteritis Trial in Canada, United States (Abatacept, Placebo)
Recruiting
- Giant Cell Arteritis
- Abatacept
- Placebo
-
Rochester, Minnesota
- +5 more
Jul 11, 2022
Palindromic Rheumatism, Wrist Trial in Barcelona (Abatacept Injection, hydroxycloroquina)
Recruiting
- Palindromic Rheumatism, Wrist
- Abatacept Injection
- hydroxycloroquina
-
Barcelona, SpainHospital Clinic i Provincial de Barcelona
Mar 24, 2022
Dermatomyositis Trial in Washington (Abatacept)
Completed
- Dermatomyositis
- Abatacept
-
Washington, District of Columbia2300 M Street, 9th floor. Medical Faculty Associates, The George
Apr 5, 2022
Abatacept in Participants That Only Recently Started to Develop
Completed
- Rheumatoid Arthritis
-
Freiburg im Breisgau, GermanyLocal Institution
Jun 10, 2022
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Myocarditis Acute, Cancer Trial in Boston (Abatacept plus, Placebo)
Recruiting
- Myocarditis Acute
- Cancer
- Abatacept plus
- Placebo
-
Los Angeles, California
- +16 more
Feb 1, 2023
Safety of Abatacept Treatment in Denmark Using Danish Database
Active, not recruiting
- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)
-
Princeton, New JerseyLocal Institution
Jun 13, 2022
GVHD, Malignancy Trial in Canada, United States (Abatacept, )
Active, not recruiting
- Graft vs Host Disease
- Malignancy
- Abatacept
- placebo
-
Los Angeles, California
- +13 more
Jan 9, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Abatacept
- +3 more
-
Buffalo, New York
- +2 more
Dec 22, 2022
Systemic Lupus Erythematosus Trial in Oklahoma City (Abatacept, Placebo)
Completed
- Systemic Lupus Erythematosus
- Abatacept
- Placebo
-
Oklahoma City, OklahomaOklahoma Medical Research Foundation
Jan 19, 2022